These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33450316)

  • 21. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation.
    Zhang H; Qi Y; Yuan Y; Cai L; Xu H; Zhang L; Su B; Nie H
    Sci Rep; 2017 Feb; 7():41887. PubMed ID: 28165507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilirubin Nanomedicine Rescues Intestinal Barrier Destruction and Restores Mucosal Immunity in Colitis.
    Rahman AT; Shin J; Whang CH; Jung W; Yoo D; Seo C; Cho BK; Jon S
    ACS Nano; 2023 Jun; 17(11):10996-11013. PubMed ID: 37227087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oridonin ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB signaling in T lymphocytes].
    Yang X; Cao X; Wei X; Zheng P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jun; 36(6):492-498. PubMed ID: 32696738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
    Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
    Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plumbagin suppresses dendritic cell functions and alleviates experimental autoimmune encephalomyelitis.
    Zhang K; Ge Z; Da Y; Wang D; Liu Y; Xue Z; Li Y; Li W; Zhang L; Wang H; Zhang H; Peng M; Hao J; Yao Z; Zhang R
    J Neuroimmunol; 2014 Aug; 273(1-2):42-52. PubMed ID: 24953531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
    Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
    Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CNS-resident classical DCs play a critical role in CNS autoimmune disease.
    Giles DA; Duncker PC; Wilkinson NM; Washnock-Schmid JM; Segal BM
    J Clin Invest; 2018 Dec; 128(12):5322-5334. PubMed ID: 30226829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
    Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
    Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
    Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy.
    Lee Y; Kim H; Kang S; Lee J; Park J; Jon S
    Angew Chem Int Ed Engl; 2016 Jun; 55(26):7460-3. PubMed ID: 27144463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with 6-Gingerol Regulates Dendritic Cell Activity and Ameliorates the Severity of Experimental Autoimmune Encephalomyelitis.
    Han JJ; Li X; Ye ZQ; Lu XY; Yang T; Tian J; Wang YQ; Zhu L; Wang ZZ; Zhang Y
    Mol Nutr Food Res; 2019 Sep; 63(18):e1801356. PubMed ID: 31313461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
    Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.